alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### BENJAMIN ROUSE v. GEORGE QUINN and others.

In a petition for a *Certiorari,*where the counsel on opposing *sides make*sworn, contradictory statements to each other, the Supreme Court will not decide between them; and taking no notice whatever of any pretended agreement between the counsel in the Court below, not appearing upon the record, this Court will hold the parties strictly to the provisions of the Code of Civil Procedure.

(The case of *Wade*v. *City of N&idbern,*72 N. C. Rep., 498; *Adams*v. *Reeves,*■„74 N. C. Rep., 106, cited and approved.)

^Petition for a *Certiorari,*filed at this Term of the Court iby.-the plaintiff in the cause, praying that an order issue to ■his Honor, Judge Kerr, before whom the cause was tried at Spring Term, 1375, of DupliN Superior Court, to settle the case and transmit it to this Court.

It is alleged in the petition that the reason the appeal was not perfected in the time prescribed, was on account of the exceptions to the case as made up by plaintiffs counsel and the absence of the Judge from the district, more time was given than the ten days prescribed in the Code.

This is positively denied in the affidavit of the defendant’s counsel, who states further, that he never at any time, during the whole proceeding, waived any right belonging to his client.

The Supreme Court declining to pass upon the issues raised by the affidavits, refused the motion for a *Certiorari,*and dismissed the original appeal for want of a case.

*Kornegay,*for petitioner.

*W. A. Alien,*contra.

Bynum, J.

The proceedings for perfecting the appeal were regular up to the time when the defendant filed his excep- . tions to the case as stated by the plaintiff.

*355Instead, then, of calling upon the presiding Judge to settle the case within the time and in the manner prescribed by law, 0. C. P., secs. 299 to 314, the plaintiff persisted in his attempt to agree on a case, with the opposing counsel, until he lost his appeal by lapse of time. It does not appear from the record that the defendant waived the bar of the lapse of time, and that he did waive it is expressly denied by him.

The propriety of the rule governing appeals, as laid down in *Wade*v. *The City of Newbern,*72 N. C. Rep., 498, and approved in *Adams*v. *Reeves,*74 N. C. Rep., 106, is apparent in this case. We have the unseemly case of two counsel of this Court on opposing sides, making sworn statements, contradicting each other upon a matter which should have appeared of record, or not been denied. We have said that in such cases this Court will not decide between them. Their opposing oaths leave the matter at large, and the provisions of the Code, as expounded in the cases cited, must prevail.

The motion is denied. The plaintiff must pay the costs of the motion. The appeal is dismissed for the want of a case.

Pee Cukiam. Appeal dismissed.
<PAGE>   1
                                                                Exhibit 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS


        We consent to the incorporation by reference in the registration
statement of Multiple Zones International, Inc. on Form S-8 (File No. 333-06961
and File No. 333-13501) of our report dated January 29, 1997, on our audits of
the consolidated financial statements of Multiple Zones International, Inc. as
of December 31, 1996 and 1995, and for the years ended December 31, 1996, 1995
and 1994, which report is incorporated by reference in this Form 10-K.


                                                   /s/ Coopers & Lybrand L.L.P.
                                                   ----------------------------
                                                       Coopers & Lybrand L.L.P.



Seattle, Washington
March 24, 1997
**EXHIBIT 15**

 

The Board of Directors

Duke Realty LimitedPartnership

 

 

Gentlemen:

 

RE:  Registration Statement No. 333-108557-01

 

With respect to thesubject registration statement, we acknowledge our awareness of the use thereinof our report dated August 12, 2005, related to our review of interimfinancial information.

 

Pursuant to Rule 436(c) underthe Securities Act of 1933, such report is not considered a part of aregistration statement prepared or certified by an accountant, or a reportprepared or certified by an accountant within the meaning of sections 7 and 11of the Act.

 

 

KPMG LLP

Indianapolis, Indiana

August 12, 2005

 

----
Exhibit 23.3

                                 August 28, 2006

El Capitan Precious Metals Inc.
Suite 216
14301 N. 87th Street
Scottsdale, AZ 85260

Gentlemen:

      The undersigned hereby consents to the reference to the undersigned in the
Annual Report on Form 10-KSB/A of El Capitan Precious Metals, Inc. for the year
ended September 30, 2005 (the "Annual Report"), including without limitation
references in Item 2 of the Annual Report, to be filed with the United States
Securities and Exchange Commission.

      I also confirm that I have read each of the references to me in the Annual
Report and concur with such statements. In giving this consent, the undersigned
does not admit that he is within the category of persons whose consent is
required by Section 7 of the Securities Act of 1933, as amended, or the rules
and regulations of the Securities and Exchange Commission.

                                    Sincerely,


                                    /s/ Richard Daniele
                                    -------------------
                                    Richard Daniele
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 6093)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Arthritis and Musculoskeletal and Skin Diseases Initial Review Group; Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Review Committee.                    

*Date:*                         March 10-11, 2015.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                    

*Contact Person:*                         Charles H Washabaugh, Ph.D., Scientific Review Officer Scientific Review Branch NIAMS/NIH, 6701 Democracy Boulevard, Suite 816, Bethesda, MD 20892, 301-594-4952,                         *washabac@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)

Dated:  January 29, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2015-02096 Filed 2-3-15; 8:45 am]

BILLING CODE 4140-01-P
Commodity 

2007 

Pounds 

Applied

2008 

Pounds 

Applied

2009 

Pounds 

Applied

ALFALFA (FORAGE - FODDER) (ALFALFA HAY) 8

ANIMAL HUSBANDRY PREMISES 0

ARRUGULA (ROQUETTE, ROCKET SALAD) 12

BOK CHOY (WONG BOK) 5 3

BROCCOLI 768 886 402

BRUSSELS SPROUTS 76 29 24

CABBAGE 162 133 34

CANTALOUPE 42 265 383

CAULIFLOWER 100 136 78

CELERY, GENERAL 152 126 14

CHINESE CABBAGE (NAPPA, WON BOK, CELERY CABBAGE) 2 14 31

CORN, HUMAN CONSUMPTION 20

COTTON, GENERAL 214 1916 326

CUCUMBER (PICKLING, CHINESE, ETC.) 148 7 18

EGGPLANT (ORIENTAL EGGPLANT) 2 1

ENDIVE (ESCAROLE) 9 8

GRAPES 3956 1003 227

GRAPES, WINE 5263 5129 3683

LANDSCAPE MAINTENANCE 29 32 43

LETTUCE, HEAD (ALL OR UNSPEC) 512 332 34

LETTUCE, LEAF (ALL OR UNSPEC) 456 212 64

MELONS 254 135 147

MUSTARD, GENERAL 1

N-GRNHS GRWN CUT FLWRS OR GREENS 74 42 116

N-GRNHS GRWN PLANTS IN CONTAINERS 485 436 530

N-GRNHS GRWN TRNSPLNT/PRPGTV MTRL 30 40 35

N-OUTDR CONTAINER/FLD GRWN PLANTS 312 237 247

N-OUTDR GRWN CUT FLWRS OR GREENS 16 19 76

N-OUTDR GRWN TRNSPLNT/PRPGTV MTRL 28 3 10

OLIVE (ALL OR UNSPEC) 0

PARSLEY (LEAFY VEGETABLE) 2

PEPPERS (CHILI TYPE) (FLAVORING AND SPICE CROP) 1 0

PEPPERS (FRUITING VEGETABLE), (BELL,CHILI, ETC.) 127 108 87

POTATO (WHITE, IRISH, RED, RUSSET) 7

PUMPKIN 40 16 27

RADICCHIO 10

REGULATORY PEST CONTROL 1 1 0

RESEARCH COMMODITY 2 1

RIGHTS OF WAY 0

Dinotefuran (044312) Cal. DPR Usage Data 

Publicly available data from the California Department of Pesticide Regulation (CADPR) was 

used to produce the following table outlining the pounds of Dinotefuran used in California over 

the three most recent years available (2007 - 2009). 
SPINACH 1 1 8

SQUASH (ALL OR UNSPEC) 71 4 17

SQUASH (SUMMER) 0 1

STRUCTURAL PEST CONTROL 1 10

SWISS CHARD (SPINACH BEET) 1

TOMATILLO 1 24

TOMATO 82 206 32

TOMATOES, FOR PROCESSING/CANNING 101 476 1499

VERTEBRATE PEST CONTROL 3 0

WATERMELONS 159 130 135

Grand Total 13701 12106 8389

Date Prepared: February 4, 2011

Cal DPR Data: http://www.cdpr.ca.gov/docs/pur/purmain.htm

Empty cells indicate no available usage.
HomeRadioactive WasteStorage of Spent Nuclear Fuel

# Dry Spent Fuel Storage Designs: NRC Approved for General Use

*This page includes links to files in non-HTML format. See Plugins, Viewers, and Other Tools for more information.*

Disclaimer: This replaces NUREG-1419, Directory of Certificates of Compliance for Dry Spent Fuel Storage Casks, which is no longer available.

Page Last Reviewed/Updated Tuesday, November 28, 2023
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 14-1103

DEREK N. JARVIS,

Plaintiff - Appellant,

v.

THE CHRISTMAS ATTIC,

Defendant - Appellee.

Appeal from the United States District Court for the Eastern 

District of Virginia, at Alexandria. Claude M. Hilton, Senior

District Judge. (1:12-cv-01010-CMH-TRJ)

Submitted: April 24, 2014 Decided: April 29, 2014

Before NIEMEYER, SHEDD, and FLOYD, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Derek N. Jarvis, Appellant Pro Se. Victor M. Glasberg, VICTOR 

M. GLASBERG & ASSOCIATES, Alexandria, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Derek N. Jarvis appeals the district court’s January 

17, 2014, order denying his motion to file a second amended 

complaint. Because we affirmed the dismissal of his previous 

complaint, the time period for filing an amended complaint had 

expired. See Fed. R. Civ. P. 15(a). Accordingly, we affirm. 

We deny Jarvis’ motion to proceed in forma pauperis, deny 

Appellee’s motion to designate Jarvis as a “vexatious litigant,” 

and dispense with oral argument because the facts and legal 

contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

AFFIRMED
# C_2004177EN.01000101.xml

| 9.7.2004 | EN | Official Journal of the European Union | C 177/1 |
| --- | --- | --- | --- |

9.7.2004

EN

Official Journal of the European Union

C 177/1

---

Euro exchange rates (1)

1

8 July 2004

(2004/C 177/01)

1 euro=

1 euro

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2348 |
| JPY | Japanese yen | 134,58 |
| DKK | Danish krone | 7,4343 |
| GBP | Pound sterling | 0,6668 |
| SEK | Swedish krona | 9,1755 |
| CHF | Swiss franc | 1,5189 |
| ISK | Iceland króna | 88,16 |
| NOK | Norwegian krone | 8,462 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5819 |
| CZK | Czech koruna | 31,457 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 250,87 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6618 |
| MTL | Maltese lira | 0,4263 |
| PLN | Polish zloty | 4,5299 |
| ROL | Romanian leu | 40 912 |
| SIT | Slovenian tolar | 239,88 |
| SKK | Slovak koruna | 39,88 |
| TRL | Turkish lira | 1 787 400 |
| AUD | Australian dollar | 1,7189 |
| CAD | Canadian dollar | 1,6345 |
| HKD | Hong Kong dollar | 9,6306 |
| NZD | New Zealand dollar | 1,8893 |
| SGD | Singapore dollar | 2,1083 |
| KRW | South Korean won | 1 420,64 |
| ZAR | South African rand | 7,5023 |

Currency

Exchange rate

USD

US dollar

1,2348

JPY

Japanese yen

134,58

DKK

Danish krone

7,4343

GBP

Pound sterling

0,6668

SEK

Swedish krona

9,1755

CHF

Swiss franc

1,5189

ISK

Iceland króna

88,16

NOK

Norwegian krone

8,462

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5819

CZK

Czech koruna

31,457

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

250,87

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6618

MTL

Maltese lira

0,4263

PLN

Polish zloty

4,5299

ROL

Romanian leu

40 912

SIT

Slovenian tolar

239,88

SKK

Slovak koruna

39,88

TRL

Turkish lira

1 787 400

AUD

Australian dollar

1,7189

CAD

Canadian dollar

1,6345

HKD

Hong Kong dollar

9,6306

NZD

New Zealand dollar

1,8893

SGD

Singapore dollar

2,1083

KRW

South Korean won

1 420,64

ZAR

South African rand

7,5023

---

(1)

1

Source: reference exchange rate published by the ECB.

Source:

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           2,405
<SECURITIES>                                         0
<RECEIVABLES>                                   14,454
<ALLOWANCES>                                       529
<INVENTORY>                                      7,112
<CURRENT-ASSETS>                                24,665
<PP&E>                                          27,243
<DEPRECIATION>                                   1,760
<TOTAL-ASSETS>                                  75,398
<CURRENT-LIABILITIES>                           29,891
<BONDS>                                         13,745
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            38
<OTHER-SE>                                      28,564
<TOTAL-LIABILITY-AND-EQUITY>                    75,398
<SALES>                                         48,143
<TOTAL-REVENUES>                                48,143
<CGS>                                           41,090
<TOTAL-COSTS>                                   41,090
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,540
<INCOME-PRETAX>                                     13
<INCOME-TAX>                                       136
<INCOME-CONTINUING>                              (123)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (123)
<EPS-PRIMARY>                                   (0.03)
<EPS-DILUTED>                                   (0.03)
        

</TABLE>
|   | (i) the Annual Report of the Company on Form 10-K for the period ended December 31, 2010 (the "Report"), fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                                         |
|------------------------------------------------------------------------------|
|                                                                         |
| /S/ MICHAEL TATE                                                             |
| Michael TateVice President and Chief Financial OfficerFebruary 16, 2011 |

|   | A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

Pursuant to the authority granted to the United States Small Business Administration under the Small Business Investment Act of 1958, as amended, under Section 309 of the Act and Section 107.1900 of the Small Business Administration Rules and Regulations (13 CFR 107.1900) to function as a small business investment company under the Small Business Investment Company License No. 03/73-0214 issued to Virginia Capital SBIC, LP, said license is hereby declared null and void.

United States Small Business Administration.

Dated: January 22, 2015.

Javier E. Saade, 

Associate Administrator for Investment and Innovation.

[FR Doc. 2015-01992 Filed 2-2-15; 8:45 am]

BILLING CODE 8025-01-P
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 21-2154V

UNPUBLISHED

JEREMY HARMON, on behalf of her

minor child, B.H.,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Chief Special Master Corcoran 

Filed: July 18, 2022

Withdrawal of petition; Order 

concluding proceedings

ORDER CONCLUDING PROCEEDINGS1

On November 10, 2021, Jeremy Harmon filed a petition for compensation on 

behalf of his minor child, B.H., under the National Vaccine Injury Compensation 

Program, 42 U.S.C. § 300aa—10 through 34.

2 Petitioner alleged that B.H. suffered 

injuries after receiving a human papillomavirus vaccination on November 1, 2018. ECF 

No. 1.

Because a decision had not been issued within the time specified in Vaccine 

Rule 10(b), a notice issued advising that “that the petitioner may withdraw the petition 

under section 300aa—21(b) of this title or the petitioner may choose under section 

300aa—21(b) of this title to have the petition remain before the special master.” 42 

U.S.C. § 300aa—12(g). On July 15, 2022, Petitioner timely filed a notice to withdraw the

petition pursuant to 42 U.S.C. § 300aa—21(b). 

In light of Petitioner’s election to withdraw the petition pursuant to 42 U.S.C. § 

300aa—21(b) (promulgated as Vaccine Rule 10(d)), Petitioner’s request to withdraw the

petition is GRANTED. Accordingly, this Order hereby notifies the Clerk of Court that 

proceedings “on the merits” of this petition are now concluded, but no judgment 

“on the merits” should be entered by the Clerk’s Office.

1 Although I have not formally designated this Order for publication, I am required to post it on the United 

States Court of Federal Claims' website because it contains a reasoned explanation for the action in this 

case, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal 

Management and Promotion of Electronic Government Services). This means the Order will be available 

to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to 

identify and move to redact medical or other information, the disclosure of which would constitute an 

unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, 

I will redact such material from public access. 

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755.
2

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master
Exhibit 32.1

                       Cancer Capital Corp.

                 CERTIFICATION OF PERIODIC REPORT
    Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
                      18 U.S.C. Section 1350

The undersigned officer of Cancer Capital Corp. certifies pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 that:

..    the annual report on Form 10-KSB of the Company for the year ended
     December 31, 2004 fully complies with the requirements of Section 13(a)
     or 15(d) of the Securities Exchange Act of 1934; and

..    the information contained in the Form 10-KSB fairly presents, in all
     material respects, the financial condition and results of operations of
     the Company.



Date:   March 25, 2005
                                     /s/ John W. Peters
                                     ____________________________________
                                     John W. Peters
                                     Principal Executive Officer
                                     Principal Financial Officer